Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France

Precision medicine in 2020: what barriers remain for drug developers?

Frontiers A Proposal for Value-Based Managed Entry Agreements in

Disease stages and treatment lines in patients with HER2-positive

A possible new reimbursement model combining different approaches

Remote Patient Monitoring Software and Services Market

Pharma industry trends: PwC

Taiwan Healthcare Market Analysis, Regulatory & Competitive Landscape

ML-based sequential analysis to assist selection between VMP and

Béchir BEN HADJ YAHIA - Roche

Consideration of prestudy clinical context and the size of

David PÉROL, Head of Department